| Study title |
ARMOR: Phase 3/4 Double-Blind, Placebo-Controlled Clinical Study to Evaluate Aramchol in Subjects with Nonalcoholic Steatohepatitis (NASH) |
| Disease or condition |
NAFLD/NASH with Fibrosis |
| Study type |
Interventional (Clinical Trial) |
| Intervention/treatment |
Aramchol or Placebo |
| Phase |
3 |
| Study site |
Duke University |
| Study location |
Durham, NC |
| Principal investigator |
Manal Abdelmalek, MD; manal.abdelmalek@duke.edu |
| Study coordinator |
Magdi Elgasim; magdi.elgasim@duke.edu |
| Phone contact |
(919) 684-9019 |
| Clinicaltrials.gov link |
https://clinicaltrials.gov/ct2/show/NCT04104321 |
